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Received July 27, 2013; accepted January 15, 2014AbstractBackground: Patients with mitral valve (MV) disease and atrial fibrillation (AF) undergo simultaneous prosthetic valve replacement and
radiofrequency (RF) ablation procedure; however, this combinational procedure restores sinus rhythm (SR) in only 68e82% of the cases. In
patients with ineffective surgical ablation, the use of a biological prosthetic valve might not only be a good choice to perform safe catheter
ablation procedure in the left atrium (LA), but also provide a way to discontinue administration of oral anticoagulants. The objective of this study
was to assess the efficacy of catheter ablation for AF after MV replacement with a biological prosthesis and an ineffective surgical ablation
procedure.
Methods: Ten consecutive patients aged 48 ± 7 years were enrolled in this study. All patients had long-persistent AF associated with a rheumatic
valve disease, which was treated by MV replacement with a biological prosthesis and a surgical RF ablation procedure. In the late postoperative
period, all the patients had recurrent hemodynamically significant AF, which required repeated cardioversions. From 1 year to 3 years after the
surgery, catheter ablation was performed, including reisolation of pulmonary veins (PVs) with the ablation of ganglionic plexi or linear lesions
on the roof of the LA and mitral isthmus. The efficacy was assessed at 3 months, 6 months, and 12 months after the procedure.
Results: Restoration of SR during ablation was achieved in all of the cases. In 6e9 months, all the patients were free of arrhythmia. LA stunning
manifested by the absence or decrease of the “A” wave in the transmitral flow and the retrograde wave in the PV flow was observed in nine
patients with SR. In five of the patients, LA contractile function was restored in 1e6 months. Prosthetic valve dysfunction was not detected in
any of the patients.
Conclusion: Catheter ablation is an effective method for AF treatment following an ineffective surgical RF ablation procedure and biological
prosthetic MV replacement. The use of bioprosthetic MVs allows for performing safe catheter ablation without subsequent prosthetic
dysfunction.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Atrial fibrillation (AF) occurs in 40e60% of patients un-
dergoing mitral valve (MV) surgery,1 and sinus rhythm (SR) is
restored in <25% of patients who underwent isolated MV
replacement.2 The traditional approach to this category of
patients involves simultaneous MV replacement andociation. All rights reserved.
Table 2
Echocardiographic data of the patients before and 6.53 ± 2.31 months after the
primary procedure.
Parameter Before mitral
valve replacement
and surgical
RF ablation
After mitral
valve replacement
and surgical
RF ablation
pa
LV end-diastolic
diameter (mm)
50e56e64 49e53e58 0.06
LV end-diastolic
volume (mL)
125e161e211 115e138e167 0.01
LV ejection fraction (%) 56e63e69 52e60e67 0.039
RV end-diastolic
diameter (mm)
16e19e23 17e19e21 0.069
LA diameter in long-axis
position (mm)
48e54e59 48e51e56 0.001
LA volume (mL) 90e108e124 74e94e103 0.01
Mitral orifice diameter
by Doppler (cm2)
10e13e19 21e25e30 0.01
Mean transmitral flow
velocity (cm/s)
111e145e150 81e91e108 0.076
Left atrioventricular
pressure gradient
(mm/Hg)
6.5e10.0e11.1 3.4e4.5e5.8 0.018
RV systolic pressure
(mm/Hg)
28e36e46 21e30e33 0.036
RA short dimension in
four-chamber position
(mm)
40e46e52 40e45e51 0.048
RA long dimension in
four-chamber position
(mm)
48e56e62 49e52e57 0.08
Data are presented as low quartileemedianehigh quartile.
LA ¼ left atrium; LV ¼ left ventricle; RA ¼ right atrium;
RF ¼ radiofrequency; RV ¼ right ventricle.
a By Wilcoxon signed-rank test.
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combinational procedure restores SR in only 68e82% of the
cases.3 Repeated open-heart ablation procedures are associ-
ated with a high risk of resternotomy and cardiolysis.4 Cath-
eter ablation might constitute an alternative approach to SR
restoration in patients who had an unsuccessful surgical
ablation procedure. Although the reported risk of complica-
tions is relatively low,5e7 the majority of interventional
arrhythmologists refrain from carrying out such procedures
because there is a risk of catheter entrapment in the obturator
elements of prosthetic MVs. In these circumstances, the use of
a biological prosthetic valve might not only be a good choice
to perform safe catheter ablations in the left atrium (LA), but
also provide a way to discontinue administration of oral
anticoagulants.
The objective of the study was to assess the efficacy of
catheter ablation for AF following an ineffective surgical RF
ablation procedure and biological prosthetic MV replacement.
2. Methods
Ten patients (aged 48 ± 7 years; 6 females and 4 males) with
long-persistent AF associated with a rheumatic valve disease
underwent simultaneous MV replacement with a biological
prosthetic valve and surgical RF ablation. The mean New York
Heart Association (NYHA) class was 2.6 ± 0.4. Data on de-
mographic and clinical characteristics as well as echocardio-
graphic features of the patients are presented in Tables 1 and 2.
The primary procedures were performed under extracorporeal
circulation and pharmacological cardioplegia. “PeriCor” and
“UniLine” (NeoCor, Kemerovo, Russia) prostheses were used
in seven and three cases, respectively. The surgical RF ablation
procedures were performed using the Cardioblate RF generator
(Medtronic, Minneapolis, MN, USA) with unipolar and bipolar
electrodes, and it included the following phases: (1) “Box”
pulmonary vein (PV) isolation or isolation of the left- and right-
sided PVs in pairs; (2) ablation of the “roof” line between the
left and right superior PVs in case of isolation of PVs in pairs;
(3) ablation of the “mitral isthmus” line between the left infe-
rior PV and MV annulus; (4) LA appendage closure; (5) abla-
tion of the line between the left superior PV and the suture on
the amputated LA appendage ostium; (6) ablation of theTable 1
Demographic and clinical characteristics of the patients.
Parameter Value
Age (y) 48 ± 7
Sex (male/female) 6/4
Stenosis/regurgitation 7/3
Rheumatic etiology 100
Long-persistent AF 100
Patients who underwent valvulotomy/valvuloplasty 20
Concomitant arterial hypertension 0
Concomitant chronic obstructive pulmonary disease 10
Diffuse euthyroid goiter 10
NYHA class prior to surgery 2.6 ± 0.4
Data are presented as % or mean ± SD, unless otherwise indicated.
AF ¼ atrial fibrillation; NYHA ¼ New York Heart Association.cavotricuspid isthmus line; and (7) ablation of lines between
the cannulation sites and the caval veins.
Despite the statistically significant favorable evolution of
LA diameter and volume in the late postoperative period
(6.53 ± 2.31 months), patients had recurrent hemodynamically
significant AF that required repeated cardioversions. In three
cases, atypical atrial flutter was also registered on the elec-
trocardiography (ECG).
Catheter ablation was performed 1e3 years after the sur-
gery. Electrophysiological study with LA mapping was carried
out in all the cases using CARTO 3 (Biosense Webster,
Diamond Bar, CA, USA) navigation mapping system and
Biotok-1000 (Biotok, Tomsk, Russia) electrophysiology
recording system. The LA was accessed through a transseptal
puncture under the control of a transesophageal echocardio-
graphic system. A bipolar amplitude map of LA and PVs was
then built in cases with AF, whereas an isochronal map was
built for cases with atrial flutter. The RF lesions were made in
an irrigated mode (rate, 17 mL/minute) with the power of 35
W and temperature of 45С using NaviStar ThermoCool and
EZ Steer ThermoCool NAV (Biosense Webster) catheters.
The variables were presented as low quartile, median, and
high quartile except age, NYHA class, and time intervals,
which were presented as means and standard deviations. All
the statistical calculations were carried out with the
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USA) using Wilcoxon signed-rank test.
3. Results
On average, recurrent arrhythmia occurred 6.53 ± 2.31
months after the surgical procedure. Endocardial electro-
physiological study was performed, and LA mappingFig. 1. Reconnection of the lower left pulmonary vein sleeve after surgical radiofre
and seventh to eighth pairs of the Lasso catheter located in the lower left pulmonar
signals are registered on the Lasso catheter recordings. CS ¼ coronary sinus.revealed recurrent AF in all the cases. The total procedural
time was 156 ± 37 minutes and the fluoroscopy time was
48 ± 19 minutes. Despite the presence of low-voltage signal,
located in previously ablated zones, the most frequent finding
was PV reconnection. These gap areas were identified by
Lasso catheter recordings without the use of adenosine tests
(Fig. 1). Therefore, reisolation of PVs was performed in all
cases (Fig. 2). The mean quantity of RF energy applicationquency ablation. (А) High-frequency signals are registered on the fifth to sixth
y vein ostium. (B) After the ablation in the gap area, only ventricular far-field
412 S.E. Mamchur et al. / Journal of the Chinese Medical Association 77 (2014) 409e415required for the closure of gaps in the isolation lines was
12.5 ± 4.6.
The reisolation of PVs led to SR restoration in four of the
10 patients. In two cases, in order to restore SR, the PV rei-
solation lesions were expanded to the ganglionic plexi areas
(Fig. 3). For ganglionic plexi ablation, the anatomical
approach described by Pokushalov et al8 was used. In the other
four patients, because AF transformed into an atypical flutter
we added linear lesions on the LA roof between the left and
right superior PVs, and/or between the right superior PV and
the roof line according to the mapping and entrainment data
(Fig. 4).
During 3 months of follow-up, IC or III class antiar-
rhythmic drugs, warfarin, and AT1-angiotensin receptor
blockers were administrated to all the patients. The follow-up
protocol consisted of physical examination, transthoracic and
transesophageal echocardiography, and 7-day ECG monitoring
performed at 3 months, 6 months, and 12 months after the
catheter procedure. The efficacy of the procedure was reported
as the freedom from any atrial arrhythmia >30 seconds.
Echocardiography was used to assess the PV blood flow and
prosthetic valve function in addition to standard hemodynamic
measurements and calculations.Fig. 2. The first stage of the procedure is pulmonary vein (PV) reisolation. (A) Bipo
are previously isolated PVs. In the ostium of the right inferior PV, the reconnection
needed to reisolate PVs and restore sinus rhythm. (C) Ablation/mapping catheter m
with sinus rhythm. Abl ¼ ablation; CS ¼ coronary sinus.During the treatment period, SR of all the patients was
registered at 6 months and 12 months. Immediately after the
procedure, atrial stunning manifested in nine cases in the
absence of atrial systole in the transmitral blood flow spectrum
and the retrograde phase of the PV blood flow (Fig. 5). Six
months after the procedure, restoration of atrial contractility
was observed in five of the nine patients (Fig. 6), which was
the reason for discontinuation of warfarin administration.
4. Discussion
According to the results of this study, the main reason for
the lack of success in surgical RF ablation procedure was PV
reconnection, and the limited number of lesions required for
PV reisolation in the majority of cases. Similar observations
were reported both in RF, cryo- or microwave surgical abla-
tions and in a classic “cut-and-sew” technique.3,9 It is very
difficult to estimate the actual number of PV reconnections,
because clinically significant recurrent AF occurs only in few
cases of reconnection.3 Even if it happens, the electrophysi-
ology study and reablation are mostly not performed, mainly
because of the risks of a repeated open-heart procedure. In
case of successful catheter ablation after a mechanicallar isoamplitude map of the left atrium (LA) in the posterior view. The red lines
region is localized. (B) Very few applications of radiofrequency energy were
oved into the LA posterior wall, in which isolated fibrillar activity is registered
Fig. 3. The second stage of the procedure is the substrate modification by ganglionic plexi ablation. (А) Atrial fibrillation still persists despite complete reisolation
of pulmonary vein (PV), confirmed by isolated ectopic activity on the ablation/mapping catheter. (B) In this patient, PV reisolation was combined with ganglionic
plexi ablation. Abl ¼ ablation; CS ¼ coronary sinus.
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cal RF ablation, all the patients will be forced to take life-long
anticoagulants. Thus, all the advantages of reablation are
nullified. In this case, the main benefit of using a biological
prosthetic valve is the possibility of discontinuing the anti-
coagulation therapy after the endothelization of the pros-
thesis.10 This opens up the possibilities of not only to restore
SR by catheter reablation but also to achieve the main goal of
biological prosthetic valve replacement, that is, the freedom
from anticoagulants, which, by contrast, might be dis-
continued once SR is restored. In half of our cases, the com-
bined use of biological prostheses and catheter reablation
allowed to achieve the maximum benefit from both
procedures.
Our results suggest that reisolation of PV even when
combined with ganglionic plexi ablation does not always lead
to SR restoration. In several cases, after AF termination, the
manifestation of atypical atrial flutter was observed. This is a
common side effect of the surgical ablation procedure,11arising from the reconduction in linear lesions mostly in the
“mitral” isthmus, which is the substrate of perimitral macro-
reentry, because of slow conduction through gaps in the lines.9
It is very difficult to make a transmural RF lesion in the thick
“mitral” isthmus wall with an open-heart or catheter tech-
nique. Therefore, we routinely use the “anterior” mitral
isthmus ablation technique, that is, make the linear lesion
between the right superior PV and the MV fibrous annulus,
which is more easily achievable than the classic “lateral”
mitral isthmus ablation.12 This approach allowed for the
restoration of SR in all the cases in our series.
Because the LA appendage was amputated in all the cases of
surgical AF ablation, and all the patients had a CHADS2 score
of 2, we discontinued anticoagulation medication in cases
with documented good LA transport functions at least 6 months
after the procedure. Pet et al13 were also of the same opinion
and they recommended discontinuation of anticoagulation
therapy 3 months after the procedure if a patient has no evi-
dence of AF, has discontinued antiarrhythmic medications, and
Fig. 4. Catheter ablation of atypical left atrial flutter. (A) Ablation designed to eliminate both perimitral reentry and the reentry around the isolated pulmonary
veins. (B) During radiofrequency ablation, atypical atrial flutter is eliminated with asystole as an outcome. Sick sinus syndrome is the most frequent complication
of the Cox maze procedure. A permanent pacemaker was implanted in this case. Abl ¼ ablation; CS ¼ coronary sinus.
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other authors also stated that permanent systemic anti-
coagulation seems to be unnecessary in patients with a good
atrial transport function after the surgical AF correction.14,15Fig. 5. (A) Left atrial stunning manifested in the absence of atrial systolic peak in
inferior pulmonary vein (PV) blood flow spectrum. (C, D) The recovery of the left a
(arrows) in the transmitral and PV blood flow, respectively.Our institute recommends discontinuation of oral anticoagu-
lants 6 months after any type of AF ablation in patients with a
biological prosthetic valve, CHADS2 score of 2, good LA
mechanical function, and the absence of AF episodes.the transmitral blood flow spectrum and (B) the retrograde peak Ar in the left
trial contractile function manifested in the recommencement of peaks A and Ar
Fig. 6. The left atrial (LA) contractile function dynamics within 12 months of
follow up: the black bars are the number of patients with stunned LA, and the
white bars show normal LA contractility.
415S.E. Mamchur et al. / Journal of the Chinese Medical Association 77 (2014) 409e415This is a pilot study, and therefore, investigating more cases
will allow for developing a more thorough approach for pa-
tients suffering from AF after an ineffective surgical ablation
procedure and bioprosthetic MV replacement.
In conclusion, catheter ablation is an effective method for
AF treatment after an ineffective surgical RF ablation proce-
dure and bioprosthetic MV replacement. The use of biological
prosthetic MV allows for performing safe catheter ablation
with subsequent anticoagulation therapy discontinuation and
without prosthetic dysfunction.
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